Try our beta test site
33 studies found for:    Open Studies | "Gastritis"
Show Display Options
Rank Status Study
1 Recruiting Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis
Condition: Gastritis
Interventions: Drug: GC6101A 37.5mg;   Drug: GC6101A 75mg;   Drug: GC6101A 150mg;   Drug: Placebo
2 Not yet recruiting The Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis
Condition: Chronic Atrophic Gastritis
Interventions: Drug: Talcid®;   Drug: Chinese medicine prescription;   Drug: Placebo;   Drug: Compound Azimtamide Entieric-coated Tablets
3 Recruiting Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea
Condition: Atrophic Gastritis
Intervention: Drug: pepsinogen and gastrin
4 Recruiting Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients
Conditions: Helicobacter Pylori Infection;   Atrophic Gastritis;   Intestinal Metaplasia
Intervention:
5 Not yet recruiting A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin
Condition: Gastritis
Interventions: Device: The results of clarithromycin susceptibility test of H. pylori isolates;   Device: Computer generated random number, randomly assigned into groups;   Device: The result of 13C-urea breath test of patient in 7days/10days/14days treatment groups
6 Recruiting A Multi-center Study for Eradication of Refractory Helicobacter Pylori
Condition: Gastritis
Interventions: Device: The result of H pylori culture based on gram staining and enzyme activity testing;   Device: The result of 13C-urea breath test after treatment based on the selection of clarithromycin, levofloxacin, metronidazole, amoxicillin,tetracycline,furazolidone and the dose of esomeprazole;   Device: The result of Amoxicillin resistance in vitro based on antibiotic susceptibility testing
7 Not yet recruiting Phase 2a Study to Evaluate Optimum Dosage and Stability of DW-3101 in Gastric Inflammation Patients
Condition: Acute and Chronic Gastric Inflammation Patients
Interventions: Drug: DW-3101_150mg;   Drug: DW-3101_300mg;   Drug: DW-3101_600mg;   Drug: Placebo
8 Recruiting A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection
Condition: Gastritis
Interventions: Device: The eradication times of the patients;   Device: The result of 13C-urea breath test after treatment
9 Recruiting Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori
Condition: Helicobacter-associated Gastritis
Interventions: Drug: Nitazoxanide;   Drug: Metronidazole(MTZ);   Drug: Omeprazole;   Drug: Clarithromycin;   Drug: Levofloxacin;   Drug: Doxicycline
10 Not yet recruiting Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication
Condition: Gastritis Associated With Helicobacter Pylori
Interventions: Drug: vonoprazan 20 mg bid;   Drug: Amoxicillin 500 mg tid;   Drug: Amoxicillin 750 mg bid;   Drug: Clarithromycin 200 mg bid;   Drug: Metronidazole 250 mg bid
11 Not yet recruiting Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia
Conditions: Chronic Atrophic Gastritis;   Intestinal Metaplasia of Gastric Mucosa
Interventions: Drug: Curcumin;   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment
12 Recruiting Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Conditions: Eosinophilic Esophagitis;   Eosinophilic Gastritis;   Eosinophilic Gastroenteritis;   Eosinophilic Colitis
Intervention:
13 Recruiting Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Conditions: Gastritis;   Gastroduodenal Ulcer
Interventions: Drug: ALBIS;   Drug: Placebo
14 Not yet recruiting System Biology of Spleen Deficiency Syndrome
Conditions: Gastritis, Atrophic;   Gastric Cancer
Intervention:
15 Not yet recruiting A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection
Conditions: Gastritis;   Gastric Ulcer
Interventions: Biological: Antibiotic selection based on the antibiotic susceptibility testing;   Genetic: PPI selection based on the CYP2C19 gene polymorphism;   Dietary Supplement: Probiotics usage based on the 16SrRNA sequencing
16 Recruiting OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
Conditions: Eosinophilic Gastrointestinal Disorders (EGIDs);   Eosinophilic Esophagitis;   Eosinophilic Gastritis;   Eosinophilic Colitis
Intervention:
17 Recruiting Gastric Cancer Screening Quality Improvement System Establishment
Conditions: Gastric Cancer;   Gastritis, Atrophic;   Intestinal Metaplasia
Intervention: Behavioral: Education and feedback
18 Recruiting Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Conditions: Helicobacter Pylori Infections;   Atrophic Gastritis;   Gastric Cancer
Intervention: Drug: Triple therapy
19 Not yet recruiting Helicobacter Pylori Genome Project
Conditions: Gastric Cancer;   Non-Atrophic Gastritis;   Intestinal Metaplasia
Intervention:
20 Recruiting Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae
Conditions: Gastritis;   Peptic Ulcer Disease;   Cholangiopathy;   Liver Fibrosis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.